|
Volume 272, Number 16,
Issue of April 18, 1997
pp. 10877-10881
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Interleukin-1 Induction of Mitogen-activated Protein Kinases
in Human Mesangial Cells
ROLE OF OXIDATION
(Received for publication, September 16, 1996, and in revised form, December 31, 1996)
William A.
Wilmer
,
Laura C.
Tan
,
Jennifer A.
Dickerson
,
Michele
Danne
and
Brad H.
Rovin
From the Department of Medicine, Ohio State University,
Columbus, Ohio 43210
Interleukin-1 (IL-1 ) significantly
influences renal cellular function through the induction of several
gene products. The molecular mechanisms involved in gene regulation by
IL-1 are poorly understood; however, the appearance of novel
tyrosine phosphoproteins in IL-1 -treated cells suggests that IL-1
may function through tyrosine phosphoprotein intermediates. The
mitogen-activated protein (MAP) kinases are tyrosine phosphoproteins
that could potentially mediate the effects of IL-1 . Protein tyrosine
phosphorylation following IL-1 treatment may be dependent on redox
changes since the IL-1 receptor is not a protein-tyrosine kinase and
oxidation has been shown to induce tyrosine phosphorylation. In this
report we demonstrate that conditioning human glomerular mesangial
cells with IL-1 results in the tyrosine phosphorylation and
activation of two members of the MAP kinase family, extracellular
signal-regulated protein kinase 2 (ERK2) and p54
Jun-NH2-terminal kinase (JNK). This effect of IL-1
is abrogated by pretreating cells with the antioxidants
N-acetyl-L-cysteine or dithiothreitol.
Furthermore, the effects of IL-1 on ERK and JNK activation are
reproduced by treating mesangial cells with membrane-permeable
oxidants. IL-1 and oxidants also cause phosphorylation and
activation of the upstream ERK regulatory element MAP kinase kinase.
Interestingly, IL-1 , but not exogenous oxidants, causes
phosphorylation of the upstream JNK activator, JNK kinase. These data
indicate that IL-1 activates ERK2 through an
oxidation-dependent pathway. Exogenous oxidants and IL-1
activate JNK through different upstream mechanisms; however,
antioxidant inhibition of JNK activation indicates that endogenous
oxidants may play a role in IL-1 -induced JNK activation. Thus
IL-1 may affect mesangial cell function by activating MAP kinases,
which can then regulate gene transcription. Furthermore, reactive
oxygen species released during inflammatory glomerular injury may also
affect mesangial function through a MAP kinase signal.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Saeedi, H. L. Parsons, R. B. Wambolt, K. Paulson, V. Sharma, J. R. B. Dyck, R. W. Brownsey, and M. F. Allard
Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms
Am J Physiol Heart Circ Physiol,
June 1, 2008;
294(6):
H2497 - H2506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Giannico, M. Mendez, and M. C. LaPointe
Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts
Am J Physiol Heart Circ Physiol,
January 1, 2005;
288(1):
H165 - H174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Taneja, P. E. Coy, I. Lee, J. M. Bryson, and R. B. Robey
Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance
Am J Physiol Cell Physiol,
August 1, 2004;
287(2):
C548 - C557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Abe, E. Sugano, Y. Saigo, and M. Tamai
Interleukin-1{beta} and Barrier Function of Retinal Pigment Epithelial Cells (ARPE-19): Aberrant Expression of Junctional Complex Molecules
Invest. Ophthalmol. Vis. Sci.,
September 1, 2003;
44(9):
4097 - 4104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.A. Wuyts, B.M. Vanaudenaerde, L.J. Dupont, M.G. Demedts, and G.M. Verleden
N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells
Eur. Respir. J.,
July 1, 2003;
22(1):
43 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Gardner, S. Eguchi, C. M. Reynolds, K. Eguchi, G. D. Frank, and E. D. Motley
Hydrogen Peroxide Inhibits Insulin Signaling in Vascular Smooth Muscle Cells
Experimental Biology and Medicine,
July 1, 2003;
228(7):
836 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sengul, C. Zwizinski, and V. Batuman
Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells
Am J Physiol Renal Physiol,
June 1, 2003;
284(6):
F1245 - F1254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cuadrado, L. F. Garcia-Fernandez, L. Gonzalez, Y. Suarez, A. Losada, V. Alcaide, T. Martinez, J. M. Fernandez-Sousa, J. M. Sanchez-Puelles, and A. Munoz
AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK
J. Biol. Chem.,
January 3, 2003;
278(1):
241 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Nathe, J. Deou, B. Walsh, B. Bourns, A. W. Clowes, and G. Daum
Interleukin-1{beta} Inhibits Expression of p21(WAF1/CIP1) and p27(KIP1) and Enhances Proliferation in Response to Platelet-Derived Growth Factor-BB in Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2002;
22(8):
1293 - 1298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. GORIN, N.-H. KIM, D. FELIERS, B. BHANDARI, G. G. CHOUDHURY, and H. E. ABBOUD
Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase
FASEB J,
September 1, 2001;
15(11):
1909 - 1920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Chan, D. W. H. Riches, and C. W. White
Redox Paradox: Effect of N-Acetylcysteine and Serum on Oxidation Reduction-Sensitive Mitogen-Activated Protein Kinase Signaling Pathways
Am. J. Respir. Cell Mol. Biol.,
May 1, 2001;
24(5):
627 - 632.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. M. Simile, M. R. De Miglio, D. Calvisi, M. R. Muroni, M. Frau, G. Asara, L. Daino, L. Deiana, R. M. Pascale, and F. Feo
Long-term dehydroepiandrosterone and 16{{alpha}}-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats
Carcinogenesis,
February 1, 2001;
22(2):
301 - 308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Thannickal and B. L. Fanburg
Reactive oxygen species in cell signaling
Am J Physiol Lung Cell Mol Physiol,
December 1, 2000;
279(6):
L1005 - L1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Laporte, P. E. Moore, T. Lahiri, I. N. Schwartzman, R. A. Panettieri Jr., and S. A. Shore
p38 MAP kinase regulates IL-1beta responses in cultured airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol,
November 1, 2000;
279(5):
L932 - L941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Tian, Z. Zhang, and D. M. Cohen
MAPK signaling and the kidney
Am J Physiol Renal Physiol,
October 1, 2000;
279(4):
F593 - F604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Z. Wang and J. C. Bonner
Mechanism of Extracellular Signal-Regulated Kinase (ERK)-1 and ERK-2 Activation by Vanadium Pentoxide in Rat Pulmonary Myofibroblasts
Am. J. Respir. Cell Mol. Biol.,
May 1, 2000;
22(5):
590 - 596.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. L. Greene, O. Houghton, G. Collinsworth, M. N. Garnovskaya, T. Nagai, T. Sajjad, V. Bheemanathini, J. S. Grewal, R. V. Paul, and J. R. Raymond
5-HT2A receptors stimulate mitogen-activated protein kinase via H2O2 generation in rat renal mesangial cells
Am J Physiol Renal Physiol,
April 1, 2000;
278(4):
F650 - F658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gupta, S. F. Rosenberger, and G. T. Bowden
Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines
Carcinogenesis,
November 1, 1999;
20(11):
2063 - 2073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kramer-Stickland, A. Edmonds, W. B. Bair III, and G.T. Bowden
Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation
Carcinogenesis,
November 1, 1999;
20(11):
2137 - 2142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pricop, J. Gokhale, P. Redecha, S. C. Ng, and J. E. Salmon
Reactive Oxygen Intermediates Enhance Fc{gamma} Receptor Signaling and Amplify Phagocytic Capacity
J. Immunol.,
June 15, 1999;
162(12):
7041 - 7048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Grewal, Y. V. Mukhin, M. N. Garnovskaya, J. R. Raymond, and E. L. Greene
Serotonin 5-HT2A receptor induces TGF-beta 1 expression in mesangial cells via ERK: proliferative and fibrotic signals
Am J Physiol Renal Physiol,
June 1, 1999;
276(6):
F922 - F930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura, and T. Osawa
Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation. 4-HYDROXY-2-NONENAL IS A POTENTIAL INDUCER OF INTRACELLULAR PEROXIDE PRODUCTION
J. Biol. Chem.,
January 22, 1999;
274(4):
2234 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Callsen, J. Pfeilschifter, and B. Brune
Rapid and Delayed p42/p44 Mitogen-Activated Protein Kinase Activation by Nitric Oxide: The Role of Cyclic GMP and Tyrosine Phosphatase Inhibition
J. Immunol.,
November 1, 1998;
161(9):
4852 - 4858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Lindroos, A. B. Rice, Y.-Z. Wang, and J. C. Bonner
Role of Nuclear Factor-{kappa}B and Mitogen-Activated Protein Kinase Signaling Pathways in IL-1{beta}-Mediated Induction of {alpha}-PDGF Receptor Expression in Rat Pulmonary Myofibroblasts
J. Immunol.,
October 1, 1998;
161(7):
3464 - 3468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Krautwald
IL-16 Activates the SAPK Signaling Pathway in CD4+ Macrophages
J. Immunol.,
June 15, 1998;
160(12):
5874 - 5879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Marrero, B. Schieffer, B. Li, J. Sun, J. B. Harp, and B. N. Ling
Role of Janus Kinase/Signal Transducer and Activator of Transcription and Mitogen-activated Protein Kinase Cascades in Angiotensin II- and Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation
J. Biol. Chem.,
September 26, 1997;
272(39):
24684 - 24690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. MacGillivray, T. F. Cruz, and C. A. G. McCulloch
The Recruitment of the Interleukin-1 (IL-1) Receptor-associated Kinase (IRAK) into Focal Adhesion Complexes Is Required for IL-1beta -induced ERK Activation
J. Biol. Chem.,
July 28, 2000;
275(31):
23509 - 23515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Robino, M. Parola, F. Marra, A. Caligiuri, R. M. S. De Franco, E. Zamara, G. Bellomo, P. Gentilini, M. Pinzani, and M. U. Dianzani
Interaction between 4-Hydroxy-2,3-alkenals and the Platelet-derived Growth Factor-beta Receptor. REDUCED TYROSINE PHOSPHORYLATION AND DOWNSTREAM SIGNALING IN HEPATIC STELLATE CELLS
J. Biol. Chem.,
December 15, 2000;
275(51):
40561 - 40567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hayama, R. Inoue, S. Akiba, and T. Sato
ERK and p38 MAP kinase are involved in arachidonic acid release induced by H2O2 and PDGF in mesangial cells
Am J Physiol Renal Physiol,
March 1, 2002;
282(3):
F485 - F491.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|